Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
28.21
+0.10 (0.36%)
Jun 27, 2025, 4:00 PM - Market closed
Fresenius Medical Care AG Revenue
Fresenius Medical Care AG had revenue of 4.88B EUR in the quarter ending March 31, 2025, with 3.32% growth. This brings the company's revenue in the last twelve months to 19.49B, up 0.10% year-over-year. In the year 2024, Fresenius Medical Care AG had annual revenue of 19.34B, down -0.61%.
Revenue (ttm)
19.49B EUR
Revenue Growth
+0.10%
P/S Ratio
0.79
Revenue / Employee
174,803 EUR
Employees
111,513
Market Cap
16.60B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 19.34B | -117.71M | -0.61% |
Dec 31, 2023 | 19.45B | 55.60M | 0.29% |
Dec 31, 2022 | 19.40B | 1.78B | 10.10% |
Dec 31, 2021 | 17.62B | -240.38M | -1.35% |
Dec 31, 2020 | 17.86B | 382.51M | 2.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
FMS News
- 11 days ago - Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency - Benzinga
- 11 days ago - Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs - WSJ
- 11 days ago - Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation - PRNewsWire
- 11 days ago - Fresenius Medical Care announces 1 bln euros share buyback programme - Reuters
- 12 days ago - 5 Stocks To Ride The German Market Rally - Benzinga
- 24 days ago - Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S. - PRNewsWire
- 4 weeks ago - Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025 - PRNewsWire
- 5 weeks ago - Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History - PRNewsWire